QT:{{”
Richard – Absolutely correct. That’s exactly what we did. We designed a study using a treatment called benralizumab. Benralizumab is an antibody therapy given by injection which specifically targets eosinophil production and migration into the lungs. We compared this with standard therapy oral corticosteroids, and indeed we had a third arm, which was a combination of the two treatments together. “}}
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
linkstream2 microblog 